Trial Profile
Investigator-Initiated Pilot Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Nov 2012 Planned End Date changed from 1 Dec 2011 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 03 Feb 2011 Planned end date changed from 1 Dec 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.